Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps FDA Compliance for Peptide Therapy and BPC 157 Holt Law BPC 157 and TB 500: Unapproved and Regulated Patrick J Moloney posted on the topic LinkedIn BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification